A multidisciplinary approach to the early detection of ovarian carcinoma: Rationale, protocol design, and early results

1993 ◽  
Vol 169 (3) ◽  
pp. 494-501 ◽  
Author(s):  
Beth Y. Karlan ◽  
Leslie J. Raffel ◽  
Gordan Crvenkovic ◽  
Cindy Smrt ◽  
M. Dwight Chen ◽  
...  
Author(s):  
Rodrigo Ortega Pérez ◽  
Ana Pardo Sanz ◽  
Valentín García Gutiérrez ◽  
José Luis Zamorano Gómez

AbstractImproved cancer survivorship has led to an increase in cardiovascular (CV) complications in the oncologic population, mainly associated with therapeutic regimens. Hence, cardio-oncology has grown toward unifying the cancer care process in which the best prevention, early detection, treatment, and CV surveillance are offered to patients. This multidisciplinary approach allows us to optimize and agree upon clinical decisions to enhance clinical outcomes. Atrial fibrillation is one of the hot topics in the field because it is still challenging in cancer patients. The optimal antithrombotic therapy remains unclear. Nevertheless, evidence supports that specific recommendations are needed due to a hemorrhagic/thrombotic disbalance present within this subgroup of patients and a low rate of anticoagulation treatments compared with the general population. Further, cardiotoxicity management is currently transforming. Increasingly, early detection of subclinical alterations is raising awareness. When medical therapy is initiated early, fewer patients progress to ventricular dysfunction and the rate of patients completing cancer therapy gradually increases. New approaches are demonstrating better outcomes and these strategies will expectedly be established in clinical practice. Cardio-oncology enables us to find the best balance between cancer treatment and CV health protection. Nowadays, more and more physicians are being instructed in this discipline, which gradually exhibits a greater presence in conferences and scientific journals. However, given the need for physicians thoroughly trained in cardio-oncology, this subspecialty must be promoted further.


Author(s):  
Damla Torul DDS, PhD ◽  
Metehan Keskin DDS ◽  
Seda Gun DDS, PhD ◽  
Didem Odabasi DDS, PhD

Odontomas can be detected as complex or compound variants and they rarely show the histologic characteristics of both types together. The tumor commonly associated with malocclusion, eruption disturbances and pathological anomalies, but they seldom cause bony expansion. Early detection and management of odontoma with multidisciplinary approach pose an important role to prevent disturbances associated with this common odontogenic tumor. Here we report a rare case of an odontoma which show the features of both complex and compound types and also cause bony expansion, eruption failure in an 8-year-old boy.


1986 ◽  
Vol 93 (12) ◽  
pp. 1286-1289 ◽  
Author(s):  
ELLIKA ANDOLF ◽  
ELIZABETH SVALENIUS ◽  
B. ASTEDT

2011 ◽  
Vol 11 (Suppl 2) ◽  
pp. S10 ◽  
Author(s):  
Clara J Witt ◽  
Allen L Richards ◽  
Penny M Masuoka ◽  
Desmond H Foley ◽  
Anna L Buczak ◽  
...  

2020 ◽  
Vol 43 (2) ◽  
pp. 2-3
Author(s):  
Lesley Beique ◽  
Jason Martyn

Background:   In collaboration with emergency physicians, the physiotherapy and pharmacy teams at RGH implemented a novel multidisciplinary, evidence-based pathway, addressing a significant care gap in the management of low back pain (LBP) in urban emergency departments (EDs).   To accomplish this, the physiotherapist conducts a neuromusculoskeletal exam, prior to the physician. They provide treatment including manual therapy, mobilization, education, home-exercises and referral to community resources. The pharmacist then reviews medications, discusses pain management, prescribes analgesia and creates a plan for outpatient analgesia. This occurs while the patient awaits the physician, avoiding increases to length of stay (LOS) and reducing burden on physicians.   Implementation: At minimum, a site wishing to implement the pathway requires a team consisting of a physiotherapist (PT) and pharmacist dedicated to the ED, called the Rapid Assessment Back Team (RABT). To operationalize the RABT successfully, the selected PT and pharmacist must be confident practitioners and have a solid understanding of LBP, red-flags, and appropriate treatment. To avoid increasing LOS, patients are seen during the 2-hour average waiting time required to see a physician. The project team consisted of physiotherapists, pharmacists, nurses, physicians, managers, and QI leaders, formed to facilitate a collaborative approach to implementation. The Prosci® ADKAR model and Plan-Do-Study-Act (PDSA) cycles were used to implement the pathway and troubleshoot operational challenges.   Evaluation Methods: Front-line staff manually collected data on response time, treatments, adverse events, and resources provided. The investigators reviewed patient charts to record opioid prescriptions, DI referrals, and arrival/discharge times of the patients. We compared outcomes of patients seen by the RABT to historical site data of patients with a discharge diagnosis of LBP from the ED.   We actively sought feedback from physicians, nurses, and the leadership group to ensure that we identified unintended consequences or near-misses early on. We reviewed interim data such as LOS and average time-to-assessment, to identify areas for improvement. This data and feedback were addressed via bimonthly PDSA cycles. We also administered patient and staff satisfaction surveys before and after site implementation of the pathway to develop an understanding of patient and staff thoughts and experiences with the service model.   Results: We studied these outcomes in 44 patients exposed to our RABT implementation. Patients who saw a physiotherapist prior to the physician had shorter median ED LOS (3.2 vs. 4.0 hours), lower diagnostic imaging rates (36.4% vs. 49.4%) and less opioid prescribing (31.8% vs. 49.2%). No patients returned to the ED within 72 hours post evaluation, compared to the 7.6% historical recidivism. Not all patients were seen by a pharmacist. When performing a subgroup analysis of patients seen by both a pharmacist and physiotherapist prior to physician, opioid prescriptions were found to drop significantly from a baseline of 49.2% to 16.7%.   Advice and Lessons Learned: Valuable learnings from the pilot include: As described above, the physiotherapist and pharmacist must be experienced and confident to be successful in the ED setting. Selection of the appropriate clinicians is crucial to achieving results, and given this is a new area of practice for many physiotherapists, a proper orientation to the setting is required. The combination of a physiotherapist and pharmacist had the largest impact on study outcomes, further confirming the need for a multidisciplinary approach to ED patient care. An “ED toolkit” can greatly facilitate service implementation for future sites, and this was developed to facilitate implementation of the RABT at another ED within the city. The toolkit consisted of items such as resources, workflows, patient handouts, sample documentation and promotional materials to increase awareness. Service hours may need some realignment with patient demand and should be geared towards minimizing service disruptions. Ideally, the physiotherapist and pharmacist would work similar hours to maximize the amount of patients able to be seen. Regular PDSA cycles to review interim data and address operational issues increases the likelihood of success by ensuring the pathway evolves to fit the contextual needs of the site. Reviewing early results motivates the team to continue to utilize the pathway. Reviewing practice issues allows clinicians to improve the care provided. One significant unintended consequence was the increase in ED LOS for patients who were referred to PT/pharmacy following physician assessment. In addition, this subgroup did not show significant reductions in opioid prescriptions or DI referrals. RABT referrals were subsequently restricted to before the physician only.


2020 ◽  
Vol 159 ◽  
pp. 98-99
Author(s):  
H. Miller ◽  
D.N. Buckley ◽  
G.C. Gooden ◽  
M.A. Spillman ◽  
L.D. Roman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document